Page last updated: 2024-10-31

metoclopramide and Hodgkin Disease

metoclopramide has been researched along with Hodgkin Disease in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research Excerpts

ExcerptRelevanceReference
"Sixty patients with Hodgkin's disease were treated with a polychemotherapy regimen including very emetic dacarbazine and adriamycin in addition to bleomycin and vincristine on 622 treatment days during the last 10 years."1.28[Management of vomiting induced by polychemotherapy in Hodgkin's disease]. ( Berényi, E; Kiss, E, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berényi, E1
Kiss, E1

Other Studies

1 other study available for metoclopramide and Hodgkin Disease

ArticleYear
[Management of vomiting induced by polychemotherapy in Hodgkin's disease].
    Orvosi hetilap, 1989, Jun-25, Volume: 130, Issue:26

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Halop

1989